- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Novel approaches and future directions in castration-resistant prostate cancer - Abstract
February 24, 2011
Prostate cancer does not influence androgen levels: A radical prostatectomy cohort study - Abstract
February 24, 2011
Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy - Abstract
February 24, 2011
Nutritional aspects of primary prostate cancer prevention - Abstract
February 24, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Initial report of RTOG 9601, a phase III trial in prostate cancer - Session Highlights
February 24, 2011
Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer - Abstract
February 23, 2011
Testicular metastases from prostate cancer - Abstract
February 23, 2011
Cost-effectiveness of prostate specific antigen screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer - Abstract
February 22, 2011
Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer - Abstract
February 22, 2011
Assessing the acceptability and usability of an interactive serious game in aiding treatment decisions for patients with localized prostate cancer - Abstract
February 22, 2011
The current status of cryotherapy and high-intensity focused ultrasound in the treatment of low-grade prostate cancer - Abstract
February 22, 2011
The effects of body mass index on changes in prostate specific antigen levels and prostate volume: Implications for prostate cancer detection - Abstract
February 22, 2011
Prostate cancer screening and informed decision-making: Provider and patient perspectives - Abstract
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Overview of translational aspects of drug development in prostate cancer - Session Highlights
February 22, 2011